Moderna

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its…

We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to…

By Patrick Wingrove and Mariam Sunny (Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of…

• Inflation data, Powell testimony, more earnings will be in focus this week. • Robinhood’s strong financial health, robust outlook,…